By clicking “Accept All Cookies” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Privacy PolicySkin Boosters Market (By Ingredient: Hyaluronic Acid (HA), Polydeoxyribonucleotides (PDRN), Poly-L-Lactic Acid (PLLA)/ Poly-D,L-Lactic Acid (PDLLA), Polycaprolactone (PCL), Exosomes; By Gender: Female, Male; By End Use: MedSpa, Dermatology Clinics; By Region: North America, LAMEA, Europe, Asia-Pacific) Industry Size, Share, Growth, Trends 2026 to 2035.
The global skin boosters market, valued at USD 1.55 billion in 2025, is projected to reach approximately USD 5.36 billion by 2035, growing at a robust CAGR of 13.20%. This surge reflects growing demand for aesthetic treatments and skin rejuvenation solutions worldwide.
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 1.55 Billion |
| Market Size in 2026 | USD 1.75 Billion |
| Market Size in 2032 | USD 3.69 Billion |
| Market Size by 2035 | USD 5.36 Billion |
| CAGR 2026 to 2035 | 13.20% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
The skin boosters could boost their footprint and expand their portfolio through brand integration and life science learning using popular hyaluronic acid. The hyaluronic acid helps fix the dehydration level in the skin. The skin boosters involve an injection process and other skin treatments or alternatives that rejuvenate and hydrate the skin. The market has experienced massive growth and demand due to an increase in skin conditions and demand for fine, desirable aging.
Other polynucleotides, exosomes, and bio-remodelling types of skin boosters are different formulas that advance the skin boosters to multiple skin areas for fast and ideal healing. The skin treatments and their sessions promote skin boosters as after-treatment skin care. The adult and geriatric population are the popular and consistent customers, elevating the skin boosters' growth and stimulating more start-up growth in the skin boosters market.
| Regions | Shares (%) |
| North America | 35% |
| Europe | 30% |
| Asia Pacific | 25% |
| LAMEA | 10% |
| Segments | Shares (%) |
| Hyaluronic acid (HA) | 40% |
| Polydeoxyribonucleotides (PDRN) | 25% |
| Poly-L-Lactic Acid (PLLA)/Poly-D,L-Lactic Acid | 20% |
| Polycaprolactone | 10% |
| Exosomes | 5% |
| Segments | Shares (%) |
| Female | 75% |
| Male | 25% |
| Segments | Shares (%) |
| MedSpa | 60% |
| Dermatology Clinics | 40% |
Published by Ajit Bansod
| Gender | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 2.09 | 2.37 | 2.68 | 3.04 | 3.44 | 3.89 | 4.40 | 4.98 | 5.64 | 6.39 | 7.23 |
| Male | 0.31 | 0.35 | 0.40 | 0.45 | 0.51 | 0.58 | 0.65 | 0.74 | 0.84 | 0.95 | 1.07 |
| End Use | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSpa | 0.93 | 1.05 | 1.19 | 1.35 | 1.53 | 1.73 | 1.96 | 2.22 | 2.51 | 2.84 | 3.21 |
| Dermatology Clinics | 0.62 | 0.70 | 0.79 | 0.90 | 1.02 | 1.15 | 1.30 | 1.48 | 1.67 | 1.89 | 2.14 |
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.54 | 0.61 | 0.70 | 0.79 | 0.89 | 1.01 | 1.14 | 1.29 | 1.46 | 1.66 | 1.87 |
| Europe | 0.47 | 0.53 | 0.60 | 0.67 | 0.76 | 0.86 | 0.98 | 1.11 | 1.25 | 1.42 | 1.61 |
| Asia Pacific | 0.39 | 0.44 | 0.50 | 0.56 | 0.64 | 0.72 | 0.82 | 0.92 | 1.04 | 1.18 | 1.34 |
| LAMEA | 0.16 | 0.18 | 0.20 | 0.22 | 0.25 | 0.29 | 0.33 | 0.37 | 0.42 | 0.47 | 0.54 |
| Subsegment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Female | 2.09 | 2.37 | 2.68 | 3.04 | 3.44 | 3.89 | 4.40 | 4.98 | 5.64 | 6.39 | 7.23 |
| Male | 0.31 | 0.35 | 0.40 | 0.45 | 0.51 | 0.58 | 0.65 | 0.74 | 0.84 | 0.95 | 1.07 |
| Subsegment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MedSpa | 0.93 | 1.05 | 1.19 | 1.35 | 1.53 | 1.73 | 1.96 | 2.22 | 2.51 | 2.84 | 3.21 |
| Dermatology Clinics | 0.62 | 0.70 | 0.79 | 0.90 | 1.02 | 1.15 | 1.30 | 1.48 | 1.67 | 1.89 | 2.14 |
| Subsegment | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.54 | 0.61 | 0.70 | 0.79 | 0.89 | 1.01 | 1.14 | 1.29 | 1.46 | 1.66 | 1.87 |
| Europe | 0.47 | 0.53 | 0.60 | 0.67 | 0.76 | 0.86 | 0.98 | 1.11 | 1.25 | 1.42 | 1.61 |
| Asia Pacific | 0.39 | 0.44 | 0.50 | 0.56 | 0.64 | 0.72 | 0.82 | 0.92 | 1.04 | 1.18 | 1.34 |
| LAMEA | 0.16 | 0.18 | 0.20 | 0.22 | 0.25 | 0.29 | 0.33 | 0.37 | 0.42 | 0.47 | 0.54 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from
